Gholam Hossein Hakimelahi
Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
[ 1 ] - Therapeutic Direction and Issues Regarding HBV Infection
With up to 400 million affected people worldwide, chronic hepatitis B virus (HBV) infection is still a major health care problem. During the last decade, several novel therapeutic approaches have been developed and evaluated. In most regions of the world, interferon-α (IFN-α), and nucleos(t)ide analogues are currently approved. Despite major improvements, none of the existing therapies is optim...
Co-Authors